agonists. An additional, non-GIRK opioid-conductance might also be occasionally modulated in neurons from vehicle-treated mice (nonreversing MENK current in 4 hyperexcitation occurs in opioid-sensitive but not of 39 cells). However, it is modulated in the majority of -insensitive PAG neurons (Chieng and Christie, 1996) . neurons during opioid withdrawal (nonreversing MENK Because postsynaptic opioid sensitivity could not be current in 24 of 37 cells, χ 2 = 24.36, p < 0.05). Additiondetermined during the cell-attached recordings in the ally, there may be some modulation of a conductance present study, the average increase in excitability (Fig- apart from GIRK channels in all neurons from morphineure 1C) represents an underestimate of the withdrawal treated animals during withdrawal, because the MENK excitation of opioid-sensitive neurons.
currents that reversed polarity positive of −136 mV did so at significantly more negative potentials than in neuChronic Morphine Treatment Induces an Additional rons from vehicle-treated mice (withdrawal, −118.1 ± Opioid-Sensitive Conductance 2.4, n = 13, versus vehicle, −107.9 ± 2 mV, n = 35; p < G protein-gated inward rectifier potassium (GIRK) chan-0.02). In addition to modulation of another conductance nels underlie the inhibition by morphine of PAG action during withdrawal, MENK induced any current in fewer potential rates in neurons from untreated animals neurons from morphine-treated mice (vehicle, 39 of 42, (Chieng and Christie, 1994; Vaughan et al., 2003) . Howversus spontaneously withdrawn, 37 of 51 cells; χ 2 = ever, in morphine-treated rats, in vitro, withdrawal by 6.34, p < 0.05) and the amplitude of the current was naloxone was not explained by reversal of opioid actismaller ( Figure 2E ). vation of GIRK channels, because the current did not
The properties of the additional conductance were reverse polarity at E K (Chieng and Christie, 1996) . This determined in isolation by blocking the GIRK channels suggests that withdrawal from chronic opioid treatment activated by MENK using BaCl 2 (1-3 mM; North and modulates an additional opioid-sensitive current. To al- Williams, 1985) . When GIRK channels were blocked, low activation and therefore study of the withdrawal-MENK (30 µM) did not produce any current in neurons induced current, slices from morphine-and vehiclefrom vehicle-treated mice ( Figure 2F , n = 5) but still produced a current in neurons from morphine-treated treated mice were spontaneously withdrawn (mor- mice. This current was outward at more negative memof an increased GIRK and decreased cation conductance, with a reversal potential of −27 mV (calculated brane potentials and reversed polarity at −40 ± 10 mV ( Figure 2F , n = 4). This is consistent with previous find-E rev for standard, normal sodium ACSF, see Experimental Procedures, Equation 3, R 2 = 0.992). Therefore, the ings in rat, where the naloxone-induced depolarization produced by withdrawal persisted in Ba 2+ (Chieng and nonreversing current MENK induced in morphinetreated mice can be explained by simultaneous activaChristie, 1996). In these experiments, the ACSF was also modified to reduce activation of voltage-activated tion of the GIRK conductance and inhibition of a cation conductance. Ca 2+ (CdCl 2 ), Na + (TTX), and K + conductances (TEACl); to reduce neurotransmitter release (0 CaCl 2 , 10 mM One candidate for the opioid-sensitive cation conductance is the hyperpolarization activated cation conMgCl 2 ); and to shift the reversal potential of mixed-cation conductances to more negative values (lower NaCl, ductance, I h , which is inhibited by opioids in nodose ganglion (Ingram and Williams, 1994) and hippocampal details in Experimental Procedures).
A current that reverses polarity at −40 mV in modineurons (Svoboda and Lupica, 1998). A small-amplitude, time-dependent I h current was observed in PAG fied, low-sodium ACSF could be due to MENK-induced activation of a Cl − conductance or a decrease in the neurons from both morphine-and vehicle-treated animals (note the current relaxation at the very negative activity of a mixed-cation conductance. The conductance was not a Cl − conductance, because the reversal potentials in Figures 2C and 2D ), but the MENKinduced current still failed to reverse polarity if the meapotential of the current was 24 mV more positive than E Cl as determined by application of the GABA A receptor surements were taken before I h was activated (beginning of voltage step, n = 37). Moreover, the reversal agonist muscimol (3 µM, −64 ± 4 mV in modified ACSF without picrotoxin, n = 4). Therefore, the reversal potenpotential of the MENK-induced current in morphinedependent mice was unaffected by the I h blocker tial of the additional conductance in the modified ACSF used here is consistent with MENK decreasing the ac-ZD7288 (50 µM), i.e., when I h was blocked, the current still did not reverse at E K , and its amplitude at −136 mV tivity of a cation conductance during withdrawal and can be described by a linear "cation" conductance was unaffected by ZD72888 (1 ± 3 pA reduction, Figure  3B , n = 4). Inhibition of GAT-1 with NO711 (10 µM) produced a small outward current (5.9 ± 2.3 pA, n = 5) in neurons from morphine-treated mice but failed to produce any current in neurons from vehicle-treated mice (−1.27 ± 3.6 pA), suggesting that GAT-1 activity is increased during opioid withdrawal. MENK (30 µM) currents in neurons from morphine-treated mice that failed to reverse polarity in the absence of NO711 subsequently reversed polarity close to E K in the presence of NO711 (10 µM for 10 min; Figures 3A and 3B). Similarly, SKF 89976A (10-100 µM for 10 min) shifted the reversal potential for the MENK-induced current close to E K (Figure 3B ; note that the mean reversal potential for withdrawn PAG neurons before application of SKF 89976A is shown to be less than −136 mV because a reversing current was observed in one of these neurons [E rev = −120 mV]). NO711 and SKF 89976A did not affect the reversal potential in neurons from vehicle-treated mice ( Figure 3B ).
These results indicate that during opioid withdrawal GAT-1 activity is increased and that when GAT-1 is inhibited MENK reverts to activating a potassium conductance in neurons from morphine-treated mice. The neurons may extend beyond the ventrolateral PAG, we TTX (1 M), and CGP55845 (1 M). MENK (30 µM) curalso examined GAT-1 immunoreactivity in the neighborrents in neurons from morphine-treated mice failed to ing brain structures. Immunoreactivity for GAT-1 was reverse polarity at the most negative potentials tested significantly greater in the lateral PAG and dorsal raphe (interleaved controls), but after pretreatment to abolish than in the ventrolateral PAG, but there was no differsynaptic release, the MENK current reversed polarity ence in any region of the PAG or dorsal raphe between close to E K (Figure 4Aiii ). The pretreatment did not affect vehicle-treated and withdrawn mice ( Figure 5C ). Therethe reversal potential of MENK currents in neurons from fore, as no difference could be detected in the total vehicle-treated mice (Figure 4Aiii ). Therefore, profoundly protein level of GAT-1 in the PAG during spontaneous reducing release of GABA (and other neurotransmitters) withdrawal using either Western blots or immunohistoabolishes opioid modulation of the GAT-1 current, indichemistry, the additional GAT-1 current is not due to cating that a dramatic reduction in the substrate remore total GAT-1 protein. duced the activity of the transporter.
Conversely, to test whether increasing neurotransmitter release is able to stimulate the current in untreated Figure 6D , n = 7), which is both consistent with activation of a cation conductance and very close to the reversal potential of the cation conductance inhibited by MENK in low-sodium ACSF during opioid withdrawal ( Figure 2F ). Dideoxyforskolin (10 µM), an analog of forskolin that does not activate adenylyl cyclase, did not induce an inward current (dideoxyforskolin, −0.5 ± 1.7 pA, n = 4, versus forskolin, −9.5 ± 4.2 pA, n = 4 at −110 mV). MENK (30 µM) currents in neurons from untreated mice that reversed polarity close to E K prior to application of forskolin no longer reversed polarity at the most negative potential tested (−136 mV) in the presence of forskolin (10 µM for 10 min, n = 6, Figure 6B ). After activation of a cation conductance by forskolin, the MENK current in neurons from untreated mice resembled the MENK current in neurons from morphine-treated mice ( Figure 2E ). In both cases, the extrapolated reversal potential of the additional cation current was close to −30 mV (normal sodium ACSF). Therefore, the GAT-1-mediated, opioid-sensitive cation conductance can be prevented by inhibition of PKA activity in morphinedependent PAG neurons and rapidly stimulated by activation of adenylyl cyclase in neurons from untreated animals. These results suggest that chronic opioid treatment increases the activity of the adenylyl cyclase cascade and that removal of opioid inhibition (i.e., withdrawal) relieves inhibition of adenylyl cyclase and allows activation of the GAT-1 conductance. Readdition of opioid agonists (MENK) inhibits the conductance via inhibition of adenylyl cyclase activity. potential rate in neurons from morphine-treated mice than in neurons from vehicle-treated mice ( Figure 7A ). By contrast, in NO711 (10 µM for 10 min), the naloxoneadenylyl cyclase activity using forskolin (10 µM) ininduced increase in action potential rate of neurons duced an inward current that was blocked by NO-711 from morphine-treated mice was similar to the increase (1 µM) in neurons from vehicle-treated mice ( Figure 6C , in neurons from vehicle-treated mice ( Figure 7A ). n = 4), but without PKA activation, NO-711 did not NO711 did not affect the smaller response to naloxone block a current in vehicle-treated mice. Therefore, PKA in vehicle-treated neurons ( Figure 7A ). These results activation can stimulate a GAT-1 current, and this sugsuggest that inhibition of GAT-1 prevents opioid modugests that opioids modulate a single additional conduclation of the cation conductance activated during opitance during withdrawal that relies on PKA and is due oid withdrawal and this prevents the increase in action potential rate produced by opioid withdrawal. to activity of GAT-1. The inward current had a reversal The hyperexcitation of PAG neurons during withfrom control animals (Chieng and Christie, 1996) . In this study, we have shown that opioid withdrawal activates drawal was also blocked by PKA inhibitors. When slices from dependent mice were maintained in moran opioid-sensitive cation current that is dependent on PKA activity and is due to GAT-1 activity. When activaphine (5 µM) and superfused with RP-CPT-cAMPs (100 µM for 10 min), subsequent naloxone (1 µM) cosuperfution of this current is prevented by inhibition of PKA or GAT-1, the elevated action potential rate of PAG neusion no longer produced a greater increase in action potential rate than in vehicle-treated mice ( Figure 7B) . rons during withdrawal is also prevented. The present RP-CPT-cAMPs did not affect the naloxone response results provide direct experimental evidence supportin neurons from vehicle-treated mice ( Figure 7B ). Thereing the suggestion that enhanced PKA signaling causes fore, PKA activity during opioid withdrawal is necessary the increase in neuronal action potential rate during for both activation of the GAT-1 cation conductance opioid withdrawal ( ., 1992; Borden et al., 1994) , and at the concentrations used in this study, other nonspecific effects of NO711 and SKF-89976A are unknown; no effects were detected in neurons from vehicle-treated mice. Additionally, NO711 lacks affinity for many other transporters, ion channels, and receptors-specifically the µ-and κ-opioid receptors (Suzdak et al., 1992) . Supporting the involvement of GAT-1, the presence of some substrate was necessary for the transporter to be active, as a dramatic reduction of vesicular GABA release prevented opioid modulation of the current.
PKA-Dependent Activation of the GAT-1 Cation Conductance Mediates Hyperexcitation of PAG
As in other brain regions, GAT-1 immunoreactivity was detected in PAG neurons that were mainly (although not exclusively) thought to be GABAergic interneurons based on anatomical criteria (Barbaresi et al., The opioid-sensitive cation conductance described in this study relies on intact PKA signaling. It is unlikely tions of GAT-1 inhibitors resulting from increased extrathat PKA phosphorylation directly modifies GAT-1 activcellular GABA (e.g., Isaacson et al., 1993), a direct ity, as the only consensus site for PKA phosphorylation effect of GAT-1 currents on action potential rate has not is extracellular (Guastella et al., 1990) . The effect of acbeen shown. In fact, only dopamine transporter curtivation of PKA on the GAT-1 transporter has not been rents have been shown to directly alter neuron action comprehensively studied, but the subcellular location, potential rate (Ingram et al., 2002 ). An elevated action enzymatic activity, and absolute level of GAT-1 is regupotential rate or depolarization due to activation of lated in a complex inter-related manner by PKC activity, GAT-1 might be predicted by the inward current in-GABA concentration, ionic conditions, tyrosine kinase duced by activating GABA transporters in horizontal activity, and the release protein syntaxin 1A (Beckman retinal cells ( can be acutely regulated by adenylyl cyclase activity. inhibitors could produce their theurapeutic effect Since there is a rebound PKA-dependent enhancement through altering extracellular GABA concentrations as of GABA release during withdrawal (Ingram et al., 1998) well as directly altering the excitability of GABAergic and stimulating adenylyl cyclase also increases GABA neurons. release in untreated animals, we considered the possibility that increased GAT-1 activity observed during Cell-attached recordings were made using patch electrodes tions, and antibody mixes. Digitized images of the caudal PAG were captured on a light microscope with a high-resolution CCD camera, (4-5 M⍀) filled with K acetate solution, as above, but excluding pluronic acid and amphotericin B. During cell-attached recordings, and ImageJ 1.32 was used to quantify immunoreactivity using densitometry. The mean gray value (MGV) of each region was meacapacitative action potentials were measured in voltage-clamp without an applied command potential and were either recorded sured in four sections from each animal, and the average MGV from the four sections was the result for the animal. The MGV of an on video tape (via Vetter PCM) and then later digitized offline in Fetchex (sampling at 5 kHz) or acquired using Axograph. After the unlabeled region of the slice was subtracted to reduce background. cell-attached recording was completed, suction was applied to establish whole-cell current clamp recording to measure resting All experiments were approved by the Royal North Shore Hospital/University of Technology Sydney Ethics committee. All membrane potential (RMP) and amplitude of action potentials. Neurons were excluded from further analyses if the RMP was more pooled data are expressed as mean ± SEM. Unless otherwise stated, we tested for significance using the unpaired Student's t positive than −45 mV or if the action potential amplitude was less than 50 mV. Data were then analyzed offline using Axograph. The test. increase in action potential rate was calculated by subtracting the 3 min preceding naloxone from the last 2 min of naloxone.
To record GABA A mIPSCs, whole-cell voltage clamp recordings
